Skip to content
Dosage GuideResearch Reference

Follistatin Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Follistatin. All information is for educational purposes only.

Quick Answer

Due to limited human trials with injectable follistatin, dosage guidelines are largely extrapolated from animal studies and gene therapy clinical trials. Gene therapy studies suggest that even low levels of follistatin expression can have a significant impact on muscle mass. Research use often involves single doses or short cycles. No consensus exists for optimal dosing.

→ Follistatin Benefits→ Follistatin Side Effects→ Full Follistatin Profile
Table of Contents

Standard Dosage Range

Research dosing range: No standardized injectable dosage range. Gene therapy trials target individual follistatin expression levels.

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Muscle Hypertrophy Research

100-300 mcg1-2x per week
Duration

4-8 weeks

Based on anecdotal reports and extrapolation from animal studies. Subcutaneous or intramuscular injection. Cycle length is typically limited due to unknown long-term effects.

Muscular Dystrophy (Gene Therapy)

N/A (Gene Therapy)Single administration
Duration

Long-term expression

Gene therapy administration is performed by qualified medical professionals and involves viral vectors delivering the follistatin gene directly into muscle tissue. Dosage is based on vector titer and targeted expression levels.

Age-Related Muscle Loss (Sarcopenia) Research

50-150 mcg1-2x per week
Duration

4-8 weeks

Lower doses are sometimes explored to mitigate potential side effects. Based primarily on theoretical benefits and extrapolation from muscle growth research.

Timing & Frequency

For injectable follistatin, timing is not critical given the half-life and mechanism of action. Gene therapy administration timing is determined by medical professionals based on the individual patient profile.

Cycle Guidance

Due to the limited human data, cycling is recommended for injectable follistatin. Common cycle lengths are 4-8 weeks followed by an equal or longer break. Gene therapy is generally a one-time treatment.

Reconstitution Reference

Quick reference for reconstituting Follistatin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically 1 mg per vial
BAC Water Volume1 mL bacteriostatic water for 1 mg/mL concentration
Concentration & DrawAt 1 mg/mL: 100 mcg = 0.1 mL (10 units on a 100-unit insulin syringe)
StorageRefrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
StabilityReconstituted solution stable up to 30 days refrigerated. Lyophilized powder stable 12-24 months per manufacturer specifications.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the typical dosage of follistatin for muscle growth?
There is no established safe or effective dosage for follistatin for muscle growth due to limited human research. Animal studies and anecdotal reports suggest potential dosages of 100-300 mcg 1-2 times per week, but these should be approached with extreme caution.
Is follistatin legal to use for bodybuilding?
The legal status of follistatin for bodybuilding purposes varies by jurisdiction. It is generally not approved for such use and may be prohibited by anti-doping agencies. Gene therapy involving follistatin is a medical procedure and is subject to regulatory oversight.
What are the potential side effects of follistatin?
Potential side effects of follistatin are not well-characterized in humans. Animal studies have reported potential cardiovascular risks, injection site reactions, and immune responses (particularly with gene therapy). The long-term effects are unknown.

Last updated: 2026-02-19